Healthware, arsenic the cardinal R&D partner, has been supporting Orion Corporation to plan and make a caller treatment, a Digital Therapeutics bundle solution “Rohkea” to dainty Chronic Pain (DTxP) utilizing Virtual Reality (VR). The efficacy and information of the merchandise has undergone a objective trial, and the results were precise promising.
During the six-week-long trial, patients’ fearfulness of question had reduced significantly, their prime of beingness had improved, and perceived content of alteration towards amended importantly improved.
Join the webinar by Healthware “Building Digital Therapeutics (DTx) – lawsuit Orion” on 2 November astatine 09:30 CET to perceive astir gathering a DTx solution, with existent beingness learnings from processing the ‘’Rohkea’’ experience. The webinar includes thoughts and experiences from our side, arsenic good arsenic from our customer, Sammeli Liikkanen from Orion Corporation.
You volition perceive from Sammeli Liikkanen, Director, Medical Medicine at Orion Corporation and Petteri Kolehmainen, Managing Director Nordics & Baltics at Healthware.
The attendance is escaped but requires registration here.